Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$165.3 - $226.0 $387,959 - $530,422
2,347 New
2,347 $504,000
Q2 2022

Aug 15, 2022

SELL
$147.53 - $266.6 $509,273 - $920,303
-3,452 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$193.94 - $261.91 $669,480 - $904,113
3,452 New
3,452 $886,000
Q3 2021

Nov 15, 2021

SELL
$170.0 - $258.58 $412,590 - $627,573
-2,427 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$164.93 - $242.23 $146,292 - $214,858
-887 Reduced 26.77%
2,427 $469,000
Q1 2021

May 14, 2021

BUY
$182.45 - $249.25 $604,639 - $826,014
3,314 New
3,314 $686,000
Q2 2020

Aug 14, 2020

SELL
$49.5 - $97.93 $593,851 - $1.17 Million
-11,997 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$41.62 - $89.92 $499,315 - $1.08 Million
11,997 New
11,997 $723,000

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $5.44B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.